Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Karyopharm Therapeutics (United States) | Researchclopedia

Back to institutions

Karyopharm Therapeutics (United States)

Newton, Massachusettscompany

825

Works

88,417

Citations

149

h-index

Top Research Topics

Nuclear Structure and Function Multiple Myeloma Research and Treatments Cancer-related Molecular Pathways

Top Researchers

Keith T. Flaherty Cancer Research Center

1,733 works121,825 citationsh-index: 146

Recent Research

Selinexor plus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: a multicenter, open-label, phase 1 study

H. Ali,Sanjay Mohan,et al.

20260 citations

Acute Myeloid Leukemia Research

Protein Degradation and Inhibitors

RNA Research and Splicing

Cancer, Lipids, and Metabolism

Ubiquitin and proteasome pathways

Lymphoma Diagnosis and Treatment

Chronic Lymphocytic Leukemia Research

RNA modifications and cancer

Myeloproliferative Neoplasms: Diagnosis and Treatment

Philip Kim Harvard University

825 works114,811 citationsh-index: 123

Jianjun Liu Agency for Science, Technology and Research

2,538 works107,091 citationsh-index: 131

Arul M. Chinnaiyan Howard Hughes Medical Institute

1,694 works97,690 citationsh-index: 144

Patrick Y. Wen Boston University

1,917 works86,971 citationsh-index: 145

Gilles Salles Memorial Sloan Kettering Cancer Center

1,720 works78,587 citationsh-index: 129

218P Development of a MUC1-C–targeted ADC as a promising therapeutic strategy for rare solid tumors

Surender Kharbanda,R. Ahmad,et al.

20260 citations

First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies

Albiruni Razak,Amit Mahipal,et al.

20260 citations

Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

Manoj Garg,Deepika Kanojia,et al.

20250 citations

CO247 The Relationship Between Surrogate Endpoints and Overall Survival in Myelofibrosis Clinical Trials: Results From a Targeted Literature Review

Louise Linsell,Yuxian Chen,et al.

20250 citations

SINE compounds activate exportin 1 degradation through an allosteric mechanism

Casey E. Wing,Ho Yee Joyce Fung,et al.

20253 citations